Mirjam Cramer
About Mirjam Cramer
Mirjam Cramer is an Associate Director of Regulatory CMC at Kite Pharma, with extensive experience in quality assurance and regulatory affairs in the pharmaceutical industry. She has held various positions at notable organizations, including Swissmedic, Senn Chemicals AG, and NDA Group AB, and holds advanced degrees in Molecular Biology and Biology.
Current Role at Kite Pharma
Mirjam Cramer serves as the Associate Director of Regulatory CMC at Kite Pharma. She has held this position since 2021. In this role, she is responsible for overseeing regulatory compliance and quality management related to Chemistry, Manufacturing, and Controls (CMC) for Kite Pharma's product development.
Previous Experience in Regulatory Affairs
Prior to her current role, Mirjam Cramer worked at Senn Chemicals AG as Chief Quality Officer and Responsible Person from 2016 to 2018. She also served as a Senior Consultant at NDA Group AB from 2018 to 2021. Her experience includes a position as a Quality (CMC) Reviewer at Swissmedic from 2008 to 2015, where she contributed to regulatory assessments.
Educational Background
Mirjam Cramer earned her Doctor's Degree in Molecular Biology from the University of Zurich, where she studied from 2001 to 2005. She also holds a Master's degree in Biology from the University of Cologne, which she completed from 1996 to 2001. Her educational background provides a strong foundation for her work in regulatory affairs.
Career Progression in Quality Assurance
Mirjam Cramer's career includes significant roles in quality assurance and regulatory affairs. She worked at Senn Chemicals AG as Manager of Quality Assurance and Regulatory Affairs for six months in 2016. Additionally, she was a Scientific Associate at CSL Behring from 2005 to 2008, where she gained further experience in the field.